DEA Issues Proposed Rule Up-Scheduling Hydrocodone Combination Products from Schedule III to Schedule II

more+
less-

On February 27, 2014, the Drug Enforcement Administration (DEA) proposed an up scheduling for hydrocodone combination products under the Controlled Substances Act (CSA) from Schedule III to Schedule II.

If the proposed rule is finalized, all of the entities and individuals who handle or prescribe hydrocodone combination products will be subject to the myriad regulatory controls governing Schedule II controlled substances.

Interested persons may submit written comments to DEA before midnight Eastern Time on April 28, 2014. The comments submitted and the identifying information of the commenter will be made part of the public record.

Please see full alert below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Topics:  Controlled Substances Act, DEA, FDA, Prescription Drugs

Published In: Health Updates, Science, Computers & Technology Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© King & Spalding | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »